Feb 21, 2024 / 09:30PM GMT
Brad O'Connor - Cogstate Limited - CEO
Good morning, everyone. Thank you for joining today's investor update, which include a discussion of our results for the half year result -- half year ended December 31, 2023. My name is Brad O'Connor, CEO of Cogstate. I'm going to be joined today by Darren Watson, who's our CFO, and by Rachel Colite, who's the Executive Vice President of our clinical trials business. Rachel has recently been promoted into that role and where she has full P&L responsibility for our clinical trials business. So excited to you to hear from her directly.
Today's presentation includes forward-looking statements. And therefore, I note our disclaimer [statement] information in this presentation is general in nature. I encourage all investors to consider your own investment objectives and also to review in detail our half year financial statements that have been lodged with the ASX this morning.
Following our presentation, we will take questions. If you have a question, there are two ways in which to ask that question. Firstly, you can type your
Half Year 2024 CogState Ltd Earnings Call Transcript
Feb 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers